Prevalence of Non-psychiatric Comorbidities in Pre-symptomatic and Symptomatic Huntington's Disease Gene Carriers in Poland
Huntington's disease (HD) is monogenic neurodegenerative disorder caused by CAG expansions within the Huntingtin gene (Htt); it has a prevalence of 1 in 10,000 worldwide and is invariably fatal. Typically, healthy individuals have fewer than 35 CAG repeats, while the CAG expansions range from 3...
Main Authors: | Daniel Zielonka, Grzegorz Witkowski, Elzbieta A. Puch, Marta Lesniczak, Iwona Mazur-Michalek, Mark Isalan, Michal Mielcarek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00079/full |
Similar Items
-
A shared mechanism of muscle wasting in cancer and Huntington's disease
by: Michal Mielcarek, et al.
Published: (2015-12-01) -
Neuro-Cardio Mechanisms in Huntington’s Disease and Other Neurodegenerative Disorders
by: Bethan J. Critchley, et al.
Published: (2018-05-01) -
Evaluation of the utility value of percutaneous drainage of symptomatic hepatic cysts combined with an obliteration attempt
by: Grzegorz Ćwik, et al.
Published: (2016-09-01) -
Bioinformatic gene analysis for potential therapeutic targets of Huntington’s disease in pre-symptomatic and symptomatic stage
by: Chunchen Xiang, et al.
Published: (2020-10-01) -
EPIDEMIOLOGY OF SYMPTOMATIC EPILEPSIES IN SMOLENSK REGION
by: N. N. Maslova, et al.
Published: (2016-05-01)